Garber Alan M Insider Trades

Insider Trading History

Track insider trading activity for Garber Alan M. See latest buy and sell transactions across all companies.

Holdings

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price

Insider Trades History

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price
Vertex Pharmaceuticals
Vertex Pharmaceuticals VRTX
Director
Holding Value $3.5M 7,344 shares
Last Trade
May 01, 2026 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$808k 1,905 shares
$423.92
$477.08
Vertex Pharmaceuticals
Vertex Pharmaceuticals VRTX
Director
Holding Value $15.7k 33 shares
Last Trade
Apr 15, 2026 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$14.6k 33 shares
$441.70
$477.08
Vertex Pharmaceuticals
Vertex Pharmaceuticals VRTX
Director
Holding Value $3.28M 6,872 shares
Last Trade
May 01, 2025 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$603k 1,199 shares
$502.97
$477.08
Vertex Pharmaceuticals
Vertex Pharmaceuticals VRTX
Director
Holding Value $1.5M 3,142 shares
Last Trade
May 01, 2024 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$1.26M 3,142 shares
$399.71
$477.08
Exelixis
Exelixis EXEL
Director
Holding Value $0 0 shares
Last Trade
Mar 21, 2024 Sale (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$562k 23,491 shares
$23.92
$55.55
Exelixis
Exelixis EXEL
Director
Holding Value $1.98M 35,703 shares
Last Trade
Mar 21, 2024 Sale (Open Market)Shares sold on the open market or in a private sale.
$461k 19,205 shares
$24.01
$55.55
Exelixis
Exelixis EXEL
Director
Holding Value $3.05M 54,908 shares
Last Trade
Mar 21, 2024 Purchase (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$562k 23,491 shares
$23.92
$55.55
Exelixis
Exelixis EXEL
Director
Holding Value $2.45M 44,087 shares
Last Trade
Jun 01, 2023 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$855k 44,087 shares
$19.39
$55.55
Vertex Pharmaceuticals
Vertex Pharmaceuticals VRTX
Director
Holding Value $3.09M 6,474 shares
Last Trade
May 01, 2023 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$597k 1,741 shares
$342.73
$477.08
Exelixis
Exelixis EXEL
Director
Holding Value $1.75M 31,417 shares
Last Trade
Feb 21, 2023 Sale (Open Market)Shares sold on the open market or in a private sale.
$700k 40,000 shares
$17.49
$55.55
Exelixis
Exelixis EXEL
Director
Holding Value $3.97M 71,417 shares
Last Trade
Feb 21, 2023 Purchase (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$698k 40,000 shares
$17.45
$55.55
Exelixis
Exelixis EXEL
Director
Holding Value $0 0 shares
Last Trade
Feb 21, 2023 Sale (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$698k 40,000 shares
$17.45
$55.55
Exelixis
Exelixis EXEL
Director
Holding Value $2.36M 42,422 shares
Last Trade
May 26, 2022 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$772k 42,422 shares
$18.19
$55.55
Vertex Pharmaceuticals
Vertex Pharmaceuticals VRTX
Director
Holding Value $2.13M 4,462 shares
Last Trade
May 01, 2022 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$1.22M 4,462 shares
$273.22
$477.08
Exelixis
Exelixis EXEL
Director
Holding Value $1.75M 31,417 shares
Last Trade
Mar 01, 2022 Sale (Open Market)Shares sold on the open market or in a private sale.
$447k 21,301 shares
$21.00
$55.55
Exelixis
Exelixis EXEL
Director
Holding Value $2.93M 52,718 shares
Last Trade
Mar 01, 2022 Purchase (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$836k 40,000 shares
$20.89
$55.55
Exelixis
Exelixis EXEL
Director
Holding Value $1.86M 33,549 shares
Last Trade
May 27, 2021 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$754k 33,549 shares
$22.48
$55.55
Vertex Pharmaceuticals
Vertex Pharmaceuticals VRTX
Director
Holding Value $2.89M 6,067 shares
Last Trade
May 01, 2021 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$1.32M 6,067 shares
$217.20
$477.08
Exelixis
Exelixis EXEL
Director
Holding Value $2.93M 52,718 shares
Last Trade
Mar 15, 2021 Purchase (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$967k 40,000 shares
$24.17
$55.55
Exelixis
Exelixis EXEL
Director
Holding Value $706k 12,718 shares
Last Trade
Mar 15, 2021 Sale (Open Market)Shares sold on the open market or in a private sale.
$944k 40,000 shares
$23.60
$55.55

See more insider trades for free

Join Stockcircle to see more insider trades and be the first to know about new executive transactions.

Sign Up